Published

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Summary by Ground News
Cancer immunotherapeutics work by unleashing the power of a patient's immune system to fight cancer. The market, which was valued at US$ 96.40 billion in 2023, is estimated to achieve a remarkable CAGR of 10.02% between the years 2023 and 2030. projections placing its value at approximately US$ 188.11 billion by the end of the decade.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.